Rifampin and isoniazid vs CYP2C9 Substrates (High risk)

Interacting Drugs
Rifampin and isoniazid
vs
CYP2C9 Substrates (High risk)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C9 Substrates (High risk): CYP2C9 Inducers (Highly Effective) may increase the metabolism of CYP2C9 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Rifampin and isoniazid vs CYP2C9 Substrates (High risk)